Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-15 Purchase | 2023-09-28 06:15 am | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 16,670 | $1.5 | $25,005 | 16,670 (Direct) | View |
| 2021-03-22 Purchase | 2021-03-22 6:35 pm | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director | 3,000 | $10.95 | $32,850 | 12,260 (Direct) | View |
| 2020-12-02 Purchase | 2020-12-02 6:05 pm | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director | 7,000 | $1.53 | $10,710 | 7,008 (Direct) | View |
| 2020-05-14 Purchase | 2020-05-18 4:16 pm | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director | 6,993 | $1.43 | $10,000 | 9,260 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-19 Option Award | 2024-02-21 8:01 pm | 2024-02-19 2034-02-19 | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Chairman | 85,000 | $0 | 99,563 (Direct) | View |
| 2022-06-09 Other | 2022-06-09 7:48 pm | 2022-06-09 2024-06-09 | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Former Director Director | 124,318 | $0 | 1,127,853 (Direct) | View |
Ownership | 2022-05-16 5:47 pm | N/A 2028-08-19 | OKYO Pharma Ltd | OKYO | BRANCACCIO JOHN P Director | 0 | $0 | 1,450,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:38 pm | 2023-03-09 2032-03-09 | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director | 26,800 | $0 | 125,317 (Direct) | View |
Ownership | 2021-12-03 4:15 pm | N/A 2031-08-01 | Accustem Sciences Inc. | ACMSY | BRANCACCIO JOHN P Director | 0 | $0 | 8,964 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:11 pm | 2022-06-10 2031-06-10 | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director | 22,000 | $0 | 98,517 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 4:34 pm | 2022-05-18 2031-05-18 | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director | 200,000 | $0 | 291,332 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 4:16 pm | 2021-08-19 2030-08-19 | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director | 30,000 | $0 | 91,332 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:16 pm | 2021-06-17 2030-06-17 | Cardiff Oncology Inc. | CRDF | BRANCACCIO JOHN P Director | 28,858 | $0 | 76,517 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 4:14 pm | 2021-04-03 2030-04-03 | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director | 60,000 | $0 | 61,275 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-25 4:16 pm | 2019-07-24 2029-07-24 | Hepion Pharmaceuticals Inc. | HEPA | BRANCACCIO JOHN P Director | 970 | $0 | 1,275 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:05 pm | 2020-06-20 2029-06-20 | Trovagene Inc. | TROV | BRANCACCIO JOHN P Director | 44,734 | $0 | 47,806 (Direct) | View |